Category Archive for: ‘Osteoporosis Medications’

New Studies Address Use of Osteoporosis Medications

The 2012 Annual Meeting of the American association of Orthopedic Surgeons was held in February in San Francisco. Two of the studies presented addressed the use of bisphosphonates and atypical femur fractures. One looked at outcomes in patients who had sustained atypical femur fractures and the other addressed whether discontinuing bisphosphonate treatment decreased the risk of a second fracture on …

Read More

Fosamax Duration of Use Questioned by FDA

In September, The FDA’s Reproductive Health Drugs Advisory Committee and the Drug safety and Risk Management Advisory Committee held a joint meeting to discuss the appropriate duration of use for Fosamax and other bisphosphonates. Earlier this year the FDA required manufacturers to include language in their labels stating that the optimal duration for patient use has not been determined and …

Read More